Credit Suisse saw its shares stabilize after the Swiss National Bank approved a loan of nearly $54 million for the company. A top investor notified Credit Suisse on Wednesday that it wouldn't be able to provide further assistance to the lender.
Share:
More In Business
Texas lawmakers try to throw a wrench into Elon Musk’s robotaxi debut
A group of Democratic Texas lawmakers is asking Elon Musk to delay his rollout of driverless ‘robotaxis’ in the state this weekend to assure the vehicles are safe enough.
How the Lakers’ new owner made his fortune
The billionaire slated to takeover the controlling interest in the Los Angeles Lakers has built a career leading businesses investing in everything from sports franchises to artificial intelligence.
IBM Gears Up for First Quantum‑Centric Supercomputer in 2025
IBM Fellow Jerry Chow talks IBM’s expansion of the Quantum Data Center in Poughkeepsie, installing Heron processors that deliver utility‑scale performance.
Big Business This Week: Market Is A Big Fan of Turbines
DNA firm is back under old management, Meta is poaching AI talent, TikTok's deadline looms, Kraft goes natural with dyes, and WhatsApp introduces ads.
New Amazon factory aims to deliver 10,000 robotaxis annually
Amazon is gearing up to make as 10,000 robotaxis annually at a sprawling plant near Silicon Valley.
How the humble water gun became the symbol of Barcelona’s anti-tourism movement
The humble water gun — the cheap, squirt-squirt variety — has become the weapon of choice and symbol of Spain's anti-tourism protests.
Trump Family Crypto Empire: A Web of Millions, Influence, and Ethical Concerns
Sam Blum, Senior Writer at Inc. Magazine, discusses one of his latest articles on why the Trump family is embracing crypto. Watch!
Real Assets Gain Traction in Bank of America's 2025 Specialty Asset Management Outlook
Ken Shepard, Head of Specialty Asset Management at Bank of America, discusses the importance of real assets and unpacks the bank's specialty asset outlook.
Cardinal Health Raises Pharmaceutical Segment Profit Guidance 12-13% for FY25
Cardinal Health's Debbie Weitzman explains how the company's Advanced Therapy Solutions Innovation Center aims to improve access to specialty medicines. Watch!
